Bio Path Correlations
| BPTH Stock | USD 0.06 0 3.00% |
The current 90-days correlation between Bio Path Holdings and NovAccess Global is -0.14 (i.e., Good diversification). The correlation of Bio Path is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Bio Path Correlation With Market
Very good diversification
The correlation between Bio Path Holdings and DJI is -0.46 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Bio Path Holdings and DJI in the same portfolio, assuming nothing else is changed.
Bio |
The ability to find closely correlated positions to Bio Path could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bio Path when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bio Path - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bio Path Holdings to buy it.
Moving against Bio OTC Stock
| 0.57 | ESCA | Escalade Incorporated | PairCorr |
| 0.51 | BKRKY | Bank Rakyat | PairCorr |
| 0.5 | NTRSO | Northern Trust | PairCorr |
| 0.49 | SOJE | Southern Company | PairCorr |
| 0.48 | POGS | Pioneer Oil Gas | PairCorr |
| 0.47 | BNL | Broadstone Net Lease | PairCorr |
| 0.47 | CMI | Cummins | PairCorr |
| 0.45 | CGON | CG Oncology Common | PairCorr |
| 0.45 | SBKO | Summit Bank Group | PairCorr |
| 0.44 | MFGCF | Mayfair Gold Corp | PairCorr |
| 0.43 | MBFJF | Mitsubishi UFJ Financial | PairCorr |
| 0.43 | MZHOF | Mizuho Financial | PairCorr |
| 0.37 | VKQ | Invesco Municipal Trust | PairCorr |
| 0.34 | CAPL | Crossamerica Partners | PairCorr |
| 0.34 | TWMIF | Tidewater Midstream and Earnings Call Today | PairCorr |
| 0.31 | ABCB | Ameris Bancorp | PairCorr |
| 0.31 | GEL | Genesis Energy LP | PairCorr |
| 0.63 | ADEA | ADEIA P | PairCorr |
| 0.53 | WEJTY | Webjet Limited | PairCorr |
| 0.47 | GL-PD | Globe Life 425 | PairCorr |
| 0.46 | INGR | Ingredion Incorporated | PairCorr |
| 0.43 | VALE | Vale SA ADR | PairCorr |
| 0.43 | ARNI | Arno Therapeutics | PairCorr |
| 0.42 | RHHVF | Roche Holding AG | PairCorr |
| 0.41 | CCL | Carnival | PairCorr |
| 0.41 | IFS | Intercorp Financial | PairCorr |
| 0.41 | WLK | Westlake Chemical | PairCorr |
| 0.38 | BCO | Brinks Company | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Bio OTC Stock performing well and Bio Path OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Bio Path's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| SECI | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| SDCCQ | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| OLMM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| VIAP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| XSNX | 12.00 | 4.24 | 0.00 | (0.88) | 0.00 | 0.00 | 480.00 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Bio Path without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run ETFs Now
ETFsFind actively traded Exchange Traded Funds (ETF) from around the world |
| All Next | Launch Module |
Bio Path Corporate Management
Elected by the shareholders, the Bio Path's board of directors comprises two types of representatives: Bio Path inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bio. The board's role is to monitor Bio Path's management team and ensure that shareholders' interests are well served. Bio Path's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bio Path's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael MBA | VP Operations | Profile | |
| Alan MacKenzie | Consultant | Profile | |
| Thomas Walker | Consultant | Profile | |
| MBA Ashizawa | Development Research | Profile | |
| Peter MBA | Chairman, CoFounder | Profile | |
| Jeffery MD | Consultant | Profile | |
| Victoria Rac | Regulatory Consultant | Profile |